financetom
Business
financetom
/
Business
/
Corning Set to Benefit From AI-Driven Fiber Demand, UBS Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Corning Set to Benefit From AI-Driven Fiber Demand, UBS Says
Sep 2, 2025 8:30 AM

11:15 AM EDT, 09/02/2025 (MT Newswires) -- Corning (GLW) remains positioned for growth as demand for fiber optics continues to exceed market expectations and glass manufacturing presents a sizable opportunity, UBS Securities said in a Tuesday note.

The firm said it expects the Optical segment to deliver about 27% in sales growth through 2027, supported by rising data center builds that require four to 16 times more fiber content as companies move towards next generation processors. UBS also pointed to potential further upside from co-packaged optics and new contracts to connect datacenters.

The brokerage added that optical profits, now about 40% of Corning, are set to become the company's main growth driver, overtaking the Display segment. UBS expects adjusted earnings per share to compound at roughly 20% annually through 2029, supporting a re-rating of the stock.

Beyond fiber, the firm noted opportunities in Corning's glass production for solar, life sciences, and automotive applications.

UBS upgraded the stock to buy from neutral and raised its price target to $84 from $65.

Shares of Corning were up 1.5% in recent trading.

Price: 68.00, Change: +0.97, Percent Change: +1.45

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved